Skip to main content
Hempsana Holdings logo

Hempsana Holdings — Investor Relations & Filings

Ticker · HMPS ISIN · CA4238651042 CSE Manufacturing
Open in API
Filings indexed 155 across all filing types
Latest filing 2024-03-21 Regulatory Filings
Country CA Canada
Listing CSE HMPS

About Hempsana Holdings

https://www.hempsana.ca

Hempsana Holdings Ltd. is a specialized manufacturer focused on cannabis derivatives extraction and purification. The company's core activities involve the production of high-quality cannabinoid oils and extracts, encompassing both major and minor cannabinoids. Hempsana specializes in processing Active Pharmaceutical Ingredient (API) grade CBD, positioning itself as a provider of high-quality inputs for medicinal and consumer applications. The company also manufactures cannabis-infused end-products, utilizing its extracts, such as full spectrum resin and distillate, often through custom manufacturing agreements for finished goods.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2024-03-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing the appointment of a Proposal Trustee following the filing of a Notice of Intention to make a Proposal under the Bankruptcy & Insolvency Act. It discusses the company's financial distress, liquidity constraints, and the initiation of a sale process under court supervision. There is no presentation of financial statements, audit results, or detailed financial performance data. The document is an announcement related to restructuring and insolvency proceedings rather than a financial report or regulatory filing of typical financial disclosures. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Audit Report. It is also not a management or board change announcement, nor a voting result or dividend notice. The content is primarily an official announcement regarding insolvency proceedings and related trustee appointment, which is best classified under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2024-03-13 English
News release - English.pdf
Regulatory Filings
2023-11-30 English
52-109FV2 - Certification of interim filings - CEO (E).pdf
Regulatory Filings
2023-11-30 English
Interim financial statements/report – English.pdf
Regulatory Filings
2023-11-30 English
News release - English.pdf
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing the Q2 and year-to-date 2023 financial results of Hempsana Holdings Ltd. It contains detailed financial highlights including net revenues, gross profit, net loss, and per share loss for the three and six months ended June 30, 2023. The presence of specific quarterly financial data and operational highlights indicates this is a comprehensive interim financial report rather than a brief earnings release or a simple announcement. The document is about 5992 characters long, which is sufficient to contain substantive financial data and analysis. Therefore, it fits the definition of an Interim / Quarterly Report (IR). H1 2023
2023-08-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.